AGF Investments Inc’s Kyntra Bio KYNB Stock Holding History

AGF Investments Inc’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-357	Closed	-$238K	–	756
2021 Q2	$238K	Buy	+357	New	+$206K	﹤0.01%	530

Other funds holding KYNB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AGF Investments Inc's KYNB Position: Q3 2021 in Review

AGF Investments Inc sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 357 shares — an estimated $238K sold.

AGF Investments Inc first reported a position in KYNB in Q2 2021 and held it in 1 quarter. The position peaked at $238K in Q2 2021. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

AGF Investments Inc reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
AGF Investments Inc sold 357 Kyntra Bio shares in Q3 2021, an estimated $238K.
AGF Investments Inc first reported a position in Kyntra Bio in Q2 2021 and held it in 1 quarter.
AGF Investments Inc's Kyntra Bio position peaked at $238K in Q2 2021.
164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on AGF Investments Inc's 13F filing for Q3 2021, filed 10 Nov 2021.